Lates News

Nuohe Nordic fell 5.7% in early trading on Wednesday. Facing pressure from price cuts in the United States and the expiration of patents in non-US regions, the company expects sales and operating profit to decline by 5% to 13% in 2026, despite the smooth progress of the oral version of Wegovy entering the market.